日前，100亿元规模的中关村战新基金发布，重庆设立首只S母基金。此外，广州上市公司高质量发展基 金落地首只子基金，宁波成立一只光学产业基金。百亿中关村战新基金发布 近日，在2025中关村论坛年会硬科技投资与发展论坛上，100亿元规模的中关村战新基金发布，该基金在 北京市西城区、北京国有资本运营管理有限公司的支持下，由中关村发展集团联合新华人寿保险股份有 限公司、工银金融资产投资有限公司等多家意向单位共同筹划设立。 据介绍，该基金将聚焦战略性新兴产业，为一批优质硬科技企业加速发展提供金融支持。中金资本设立 一只氢能基金 日前，中金资本作为管理人及普通合伙人，与辛集建设投资有限公司、河北省科技金融发展促进中心共 同发起设立中金(辛集市)氢能创业投资基金合伙企业(有限合伙)(以下简称"中金辛集氢能基金")。 广州上市公司高质量发展基金成立于2024年12月，目标规模100亿元，首期规模10亿元，由广州金控集团 和万联证券各自认缴50%，万联证券的全资私募子公司万联天泽担任基金管理人。西安成立一只食品和 生物医药产业基金 近日，陕西金港农投生物医药产业基金，在中国证券投资基金业协会完成备案，这是西安市工业倍增引 导基 ...

Group 1 - The 2025 Zhongguancun Forum held in Beijing from March 27 to 31 focused on the future of cutting-edge technology, with artificial intelligence (AI) being a central theme discussed across various industries [1][2][3] - The forum highlighted the role of AI in accelerating industrial green and low-carbon transformation, contributing to the achievement of carbon peak and carbon neutrality goals [2][4] - Experts predict that 2025 will be a year of explosive growth in AI applications, with advancements in large models and the integration of AI with physical reality [5][7] Group 2 - The forum featured innovative cases demonstrating how AI technologies, such as brain-computer interfaces and exoskeleton robots, are helping individuals with disabilities regain mobility [2][17] - A digital emergency rescue system called "5-Minute Social Rescue Circle" has been implemented in eight cities, successfully aiding 21,950 patients, including 1,012 cardiac arrest cases [11][13] - The integration of AI in emergency medical services is expected to enhance response times and improve survival rates for critical conditions [11][12] Group 3 - The forum showcased over 128 activities, including discussions on large models, embodied intelligence, 6G technology, and quantum technology, with AI being a focal point for scholars and entrepreneurs [4][6] - The development of embodied intelligence is seen as a crucial step towards achieving artificial general intelligence (AGI), with significant investments pouring into this sector [8][10] - Challenges remain in the commercialization of humanoid robots and embodied intelligence, with concerns about high costs and insufficient data hindering broader application [8][10] Group 4 - The forum emphasized the importance of collaboration among various stakeholders to address challenges in AI and embodied intelligence, including reducing hardware costs and building a shared data ecosystem [10][19] - The anticipated rollout of 6G technology is expected to enhance the capabilities of AI systems and robots, facilitating real-time interaction with the physical world [10][19] - The integration of AI in healthcare is transforming emergency response systems, with a focus on improving efficiency and decision-making in critical situations [11][14] Group 5 - The forum included a parallel session on technology for assisting people with disabilities, showcasing 15 innovative assistive technology projects [16][18] - Technologies such as smart bionic hands and brain-computer interfaces are being developed to improve the quality of life for individuals with disabilities [17][18] - The potential for AI and new technologies to empower disabled individuals and enhance their participation in society was a key discussion point [19]

Group 1: Technological Innovation and Development - The 2025 Zhongguancun Forum highlights China's commitment to innovation-driven development, with R&D expenditure reaching 3.6 trillion yuan in 2024 and an R&D intensity of 2.68% [1] - China has established technology cooperation with over 160 countries and regions, signing 118 intergovernmental agreements, positioning Beijing as a strategic hub for technological innovation [2] - The forum showcased humanoid robots as a key focus, with applications in the automotive sector, emphasizing the importance of reducing data costs for large-scale industrialization [3][4] Group 2: Advancements in Electric Vehicles - The forum announced significant technological achievements, including the "AI + New Materials" initiative, with Xiaomi's automotive project utilizing advanced materials for enhanced vehicle performance [5] - Li Auto introduced its self-developed operating system, Li Xiang Star Ring OS, aimed at reducing BOM costs by billions annually, marking a significant step in automotive intelligence [6] - Beijing's efforts in promoting technology transfer have led to a thriving ecosystem with nearly 30,000 national high-tech enterprises and significant growth in strategic emerging industries like AI and electric vehicles [7] Group 3: Showcase of Smart New Energy Vehicles - The forum featured a dedicated exhibition area for smart connected new energy vehicles, with Xiaomi showcasing its SU7 models and various in-car products [8] - Innovative technologies such as the rubber-wheeled guided transit vehicle were highlighted, demonstrating advancements in public transport automation and energy efficiency [8][9] - The event underscored the automotive sector's role as a representative of new productive forces, showcasing China's rapid development in this field [9]

Core Viewpoint - Beijing Zhongguancun Science and Technology Development (Holding) Co., Ltd. announced that its subsidiary, Beijing Huasu Pharmaceutical Co., Ltd., has been selected in the 10th batch of national drug centralized procurement for its product, Naloxone Hydrochloride Injection, which is expected to positively impact the company's future performance and market presence [1][2]. Group 1: Product Information - Product Name: Naloxone Hydrochloride Injection - Dosage Form: Injection - Specification: 1ml:1mg - Packaging: 10 vials/box - Indications: Used for reversing respiratory depression caused by opioid drugs, treating opioid overdose, and diagnosing acute opioid overdose [1][2]. Group 2: Procurement Details - Selected Price: 0.99 yuan per vial - Supply Provinces: Inner Mongolia, Liaoning, Jilin, Hunan, Qinghai - Backup Supply Provinces: Beijing, Tianjin, Zhejiang, Anhui, Jiangxi - Selected Company: Beijing Huasu Pharmaceutical Co., Ltd. [2]. Group 3: Impact on the Company - The selected product is classified as a Class A product under the national medical insurance scheme, with a procurement period from the selection date until December 31, 2027 - Medical institutions will prioritize the use of selected products, which is expected to enhance the company's sales channels and market share for Naloxone Hydrochloride Injection - The successful implementation of procurement contracts will contribute positively to the company's operational performance and long-term development [2].

Group 1: Company Announcements - WuXi AppTec announced the sale of 50.8 million shares of WuXi AppTec Holdings through block trading, with a transaction amount of approximately HKD 2.178 billion, resulting in an investment gain of about RMB 1.847 billion, which accounts for over 10% of the company's latest audited net profit attributable to shareholders [1] - Jinlongyu plans to invest RMB 1.2 billion to construct a production line for key materials for solid-state batteries in Huizhou New Materials Industrial Park [2] - Dazhu CNC is conducting preliminary research on the issuance of overseas securities (H shares) and listing [3] - Anyuan Coal Industry plans to acquire 57% of Jinhui Magnetic Separation and simultaneously divest its coal business, which is expected to constitute a major asset restructuring [4] - Yuntian Lifa announced that its subsidiary has completed the delivery and acceptance of AI training and inference computing power services, positively impacting the company's operational performance [5] - AVIC Industry plans to voluntarily withdraw its A-share listing and will be suspended from trading starting April 3, 2025 [6] Group 2: Financial Performance - Naipu Mining reported a 45.46% year-on-year increase in net profit for 2024 and plans to distribute a cash dividend of RMB 0.7 per 10 shares [7] - New Hope expects a profit of RMB 430 million to RMB 500 million in the first quarter, marking a turnaround from losses [7] - Jinbei Automobile reported a net profit of RMB 382 million for 2024, a year-on-year increase of 214.06% [7] - Hailu Heavy Industry anticipates a year-on-year net profit increase of 50% to 65% for the first quarter of 2025 [8] Group 3: Major Transactions and Investments - Baiyin Nonferrous Metals completed the acquisition of a mining company's equity, increasing its copper metal resources to approximately 930,000 tons [9] - Ningbo Port expects to complete a container throughput of 12.11 million TEUs in the first quarter, a year-on-year increase of 10.9% [11] - Huafeng Communication reported a year-on-year net profit increase of 38.38% for 2024 [11] - Kid King anticipates a year-on-year net profit increase of 72.44% for 2024 and plans to distribute a cash dividend of RMB 0.5 per 10 shares [11]

新华社石家庄4月2日电 题：特写：当"世界的中关村"遇见"未来之城" 2017年4月1日，新华社受权发布：中共中央、国务院决定设立河北雄安新区。8年来，雄安新区城市发 展日新月异，科技创新活力迸发。以梅卡曼德为代表的高新技术企业纷纷向雄安新区集聚，其中许多企 业选择入驻雄安新区中关村科技园。 这是雄安新区中关村科技园（2025年3月29日摄，无人机照片）。新华社记者 落飞麟 摄 梅卡曼德机器人科技有限公司工作人员（左）讲解该公司智能机器人产品与技术（2024年11月26日 摄）。新华社记者 落飞麟 摄 新华社记者黄昱璋、白林、落飞麟 走进梅卡曼德机器人科技有限公司的展厅，一款智能机械臂令人眼前一亮：通过公司推出的Mech-GPT 多模态大模型，操作员无需掌握专业知识，只需发出语音指令，即可让机械臂完成复杂任务。 作为国家级专精特新"小巨人"企业，梅卡曼德的主打技术是为传统机械臂装上"眼睛"和"大脑"。目前， 梅卡曼德是全球AI+工业机器人领域融资额最高、技术最全面、案例最多、应用领域最广的公司之一， 其产品远销全球50多个国家和地区。 2024年，梅卡曼德将总部从北京迁至雄安新区，期待在这座"未来之城"大展宏 ...

Core Insights - AI for Science is becoming a significant trend in contemporary scientific research, showcasing immense potential in enhancing research efficiency, transforming research paradigms, and accelerating scientific discoveries [1][2]. Group 1: Development and Impact of AI for Science - AI for Science breaks down three boundaries: the boundaries between disciplines, between theory and experimentation, and between industry and academia [1]. - The approach of AI for Science significantly enhances the capacity for scientific discovery and technological output, thereby improving productivity [2]. - The platform model promoted by AI for Science facilitates collaboration across the industry chain, leading to faster conversion of research results into industry applications [2]. Group 2: Tools and Efficiency - The efficiency of research tools has seen remarkable improvement, exemplified by the Science Navigator, an AI-assisted literature retrieval and research tool developed by the Beijing Academy of Science Intelligence [2]. - Traditional literature research methods are time-consuming and labor-intensive, while AI technology combined with vast literature databases allows for rapid retrieval and concise summarization of relevant scientific research [2]. - This efficiency boost not only optimizes research processes but also opens up more possibilities for interdisciplinary research [2][3]. Group 3: Broader Implications - AI for Science is expected to empower various industries, including energy, materials, chemicals, and biomedicine, leading to profound transformations [4]. - The introduction of AI technology in industrial software could result in efficiency improvements by hundreds of times [4]. - This period is viewed as a historic window of opportunity for addressing shortcomings in the research field and achieving significant advancements [4].

3月27日，2025中关村论坛年会（以下简称"论坛年会"）在北京开幕，吸引全球百余个国家和地区的创 新领袖，共同探讨"新质生产力与全球科技合作"。 今年论坛年会的耐心资本服务新质生产力论坛上，君联资本总裁李家庆透露，社保基金中关村自主创新 专项基金已向16个项目决策投资30亿元，其中：超过70%的资金投向北京，近40%投资企业曾获国家科 技进步奖或承担重大科技攻关项目，"专精特新"企业占比近70%，"小巨人"企业占比约45%。 去年以来，耐心资本在不同场合被多次提及。"耐心资本作为科技、产业、金融三角循环的传动轴，已 成为培育新质生产力的核心动能，'范式变化'正在深刻地影响着中国股权投资市场。"李家庆认为，耐 心资本正逐步深化，成为推动科技创新的关键力量。"在新发展格局下，我们看到股权投资机构迎来了 新的机遇和使命。" 本次论坛年会期间，李家庆接受21世纪经济报道记者采访，介绍了社保基金中关村自主创新专项基金的 情况，以及团队对"耐心资本北京模式"的探索和实践。在他看来，"耐心资本北京模式"不仅是通过制度 创新释放经济创新动能的战略实践，还在于构建起"有效市场+有为政府+市场化专业机构+北京优势"协 同发力的 ...

Core Points - The 2025 Zhongguancun Forum was held from March 27 to 31 in Beijing, focusing on innovation and collaboration in technology [1] - Shanxi Province actively participated as an innovation cooperation partner, showcasing its achievements in transforming traditional industries and developing emerging sectors [2][5] - The forum included various activities such as the "Shanxi Industrial Digital Innovation Development Conference" and discussions on artificial intelligence and quantum technology [2][4] Group 1 - The forum aimed to enhance Shanxi's global influence and attract high-quality scientific and technological resources [2][5] - Key experts, including members from the Chinese Academy of Engineering, shared insights on advanced topics, contributing to the dialogue on digital industry development in Shanxi [2][5] - The collaboration between Shanxi and Zhongguancun Development Group focuses on building an innovative service system that integrates industry, academia, and finance [3] Group 2 - The forum received positive feedback for Shanxi's transformation practices and openness, creating favorable conditions for attracting high-end resources [5] - The event featured a variety of formats, including promotional videos, expert reports, and high-quality roundtable discussions, showcasing Shanxi's new achievements in transformation [5] - The forum's theme, "New Quality Productivity and International Scientific Cooperation," included multiple sessions and activities aimed at fostering ongoing collaboration [6]

关于盐酸纳洛酮注射液中选第十批全国药品集中采购的公告 共 2 页 证券代码：000931 证券简称：中关村 公告编号：2025-036 北京中关村科技发展（控股）股份有限公司 关于盐酸纳洛酮注射液中选第十批全国药品集中采购的公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚假 记载、误导性陈述或重大遗漏。 北京中关村科技发展（控股）股份有限公司（以下简称：公司）下属公司北 京华素制药股份有限公司（以下简称：北京华素）参与了第十批国家组织药品集 中采购工作，根据国家组织药品联合采购办公室于近日发布的《关于公布全国药 品集中采购（GY-YD2024-2）中选结果的通知》显示，北京华素生产的盐酸纳洛 酮注射液中选本次集中采购，现将相关情况公告如下： 药品名称：盐酸纳洛酮注射液 剂型：注射剂 规格：1ml：1mg 包装规格：10 支/盒 适应症：本品为阿片类受体拮抗药。1、用于阿片类药物复合麻醉药术后， 拮抗该类药物所致的呼吸抑制，促使病人苏醒。2、用于阿片类药物过量，完全 或部分逆转阿片类药物引起的呼吸抑制。3、解救急性乙醇中毒。4、用于急性阿 片类药物过量的诊断。 中选价格：0.99 元/支 ...